Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

2.44
Delayed Data
As of Feb 05
 -0.04 / -1.61%
Today’s Change
1.63
Today|||52-Week Range
26.25
+20.79%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close2.48
Today’s open2.44
Day’s range2.42 - 2.52
Volume12,068
Average volume (3 months)30,307
Market cap$8.5M
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+26.19%
Earnings growth (this year)+19.35%
Earnings growth (next 5 years)--
Revenue growth (last year)-69.69%
P/E ratioNM
Price/Sales29.66
Price/Book2.73

Competitors

 Today’s
change
Today’s
% change
GNVCGenVec Inc-0.00-0.39%
RTTRRitter Pharmaceutica...-0.09-6.72%
ECTEEcho Therapeutics In...-0.10-10.00%
CPHIChina Pharma Holding...+0.00+1.39%
Data as of 3:59pm ET, 02/05/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$31.25
Annual revenue (last year)$1.1M
Annual profit (last year)-$15.2M
Net profit margin-1,441.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
CFO, CAO, Secretary &
Treasurer
Thomas J. Paulson
Corporate headquarters
Emeryville, California

Forecasts

Partner Offers